Arcellx Stock (NASDAQ:ACLX), Quotes and News Summary

Q: What sector and industry does Arcellx (ACLX) operate in?

Arcellx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Arcellx Stock (NASDAQ: ACLX) stock price, news, charts, stock research, profile.

Open	$51.810
Close	$49.740
Volume / Avg.	925.475K / 452.046K
Day Range	47.880 - 52.730
52 Wk Range	30.740 - 75.100
Market Cap	$2.651B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	8.63%
Days to Cover	9.76

Recent News

Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley

Morgan Stanley initiates coverage on Arcellx. Uncover the potential of ddBCMA in blood cancer treatment, featuring a differentiated CAR-T platform. Analysts project $5 billion in peak sales.

Vandana Singh

Arcellx Analysts Boost Their Forecasts After Q4 Results

Arcellx, Inc. (NASDAQ: ACLX) posted financial results for its fourth quarter on Wednesday.

Avi Kapoor

Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024

Needham analyst forecasts positive outlook for Arcellx Inc (ACLX) in 2024, citing potential from pivotal interim readout & strong data from Phase I study, raising price target & adding to Conviction List.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arcellx (ACLX) stock?

You can purchase shares of Arcellx (NASDAQ: ACLX) through any online brokerage.

View our list of the best stock brokerages.

Who are Arcellx's (ACLX) competitors?

Other companies in Arcellx’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and MoonLake (NASDAQ:MLTX).

What is the target price for Arcellx (ACLX) stock?

The latest price target for Arcellx (NASDAQ: ACLX) was reported by Needham on Friday, May 10, 2024. The analyst firm set a price target for 81.00 expecting ACLX to rise to within 12 months (a possible 62.85% upside). 33 analyst firms have reported ratings in the last year.

Current Stock Price for Arcellx (ACLX)?

The stock price for Arcellx (NASDAQ: ACLX) is $49.74 last updated May 10, 2024 at 4:00 PM EDT.

Does Arcellx (ACLX) pay a dividend?

There are no upcoming dividends for Arcellx.

When is Arcellx (NASDAQ:ACLX) reporting earnings?

Arcellx’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Arcellx (ACLX) going to split?

There is no upcoming split for Arcellx.

What sector and industry does Arcellx (ACLX) operate in?

Arcellx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-